Test Price
2,800 AED✅ Home Collection Available
TET2 Gene Myelodysplastic Syndrome (Somatic) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TET2 لمتلازمة خلل التنسج النقوي (الجسدي) بتقنية التسلسل الجيني الفائق في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
99.9% Diagnostic Sensitivity – ISO-certified laboratory processing using high-depth Next‑Generation Sequencing (NGS) with orthogonal confirmation. This test identifies acquired (somatic) mutations in the TET2 gene critical for the diagnosis, prognosis, and therapeutic stratification of myelodysplastic syndromes.
Premium Logistics: Paid hospital‑grade home collection via ISO‑certified cold‑chain transport; VIP mobile phlebotomy available 8 AM‑11 PM across all emirates.
Clinical Guidance: Complimentary telephonic post‑test clinical correlation session with a DHA‑licensed specialist to interpret results in the context of your haematology work‑up.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
ملخص تنفيذي
يضمن تحليل جين TET2 باستخدام تقنية التسلسل الجيني الفائق (NGS) أعلى دقة تشخيصية لحالات متلازمة خلل التنسج النقوي (MDS) الجسدية، مع استشارة وراثية قبل وبعد الفحص وفق معايير هيئة الصحة بدبي وهيئة تنظيم قطاع الاتصالات والحكومة الرقمية.
Overview
The TET2 somatic mutation NGS test detects acquired variants in the TET2 gene, a key epigenetic regulator. In the UAE, this assay is used to subtype myelodysplastic syndromes, refine IPSS‑R risk scores, and guide eligibility for emerging targeted therapies. يُستخدم هذا التحليل الجيني الجسدي لتحديد الطفرات في جين TET2 المرتبطة بمتلازمة خلل التنسج النقوي، مما يساعد في تحديد الإنذار والعلاج.
| Feature | Our Test – TET2 Somatic NGS | Closest Alternative – Broad Myeloid Panel |
|---|---|---|
| Depth of Coverage | ≥500× unique reads across all TET2 coding exons | 100–300× (variable) |
| Method | Targeted NGS + Sanger validation for reportable variants | Multiplex PCR‑based NGS (50+ genes) |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Clinical Relevance | Focused on acquired TET2 variants; clear prognostic significance for MDS | Many genes; TET2 analysis may be diluted by lower depth and incidental findings |
Physician Insight & Safety Protocol
“As a haematopathologist, I emphasise that a TET2 mutation alone does not diagnose MDS; it must be correlated with blood counts, bone marrow morphology, and cytogenetics. However, a positive result strongly refines risk stratification and may open avenues for clinical trial enrolment. Please rely on your haematologist‑oncology team to integrate this information into your personalised care plan.”
— Dr. Prabhakar Reddy, DHA License No. 61713011, Senior Specialist Haematology
Medication Warning
Do not discontinue prescribed medication (e.g., erythropoiesis‑stimulating agents, iron chelators, or hypomethylating agents) without explicit instruction from your consultant. Genetic test results should always be interpreted in conjunction with your ongoing treatment regimen.
Safety & Exclusion Criteria
- Exclusion Criteria: Patients unwilling or unable to complete a pre‑test genetic counselling session; known severe anaemia (Hb <7 g/dL) where venipuncture may pose risk; active life‑threatening haemorrhage.
- Emergency Red Flags: If you develop sudden severe bleeding, uncontrolled infection, or acute chest pain, stop and seek emergency medical care immediately — do not wait for genetic results.
- Paediatric note: Federal Decree‑Law No. 41 of 2024 and CDS Law 2026 mandate consent from a legal guardian for minors; all data handled under UAE PDPL.
Frequently Asked Questions
What is the TET2 gene somatic mutation test for myelodysplastic syndrome?
The TET2 gene mutation test detects acquired (somatic) mutations in the TET2 gene associated with myelodysplastic syndromes to guide diagnosis, prognosis, and targeted therapy decisions.
يكشف تحليل طفرات جين TET2 الجسدية عن التغيرات الجينية المكتسبة في الجين TET2 المرتبطة بمتلازمة خلل التنسج النقوي، مما يساعد في توجيه التشخيص وتقدير الإنذار وتحديد خيارات العلاج الموجه.
How long does it take to receive TET2 somatic NGS results in Dubai?
Results are typically finalised within 3 to 4 weeks from receipt of a properly collected blood or DNA sample at our ISO-accredited laboratory.
تظهر النتائج عادةً خلال 3 إلى 4 أسابيع من استلام العينة الدموية أو عينة الحمض النووي المحفوظة ببطاقة FTA لدى مختبرنا الحاصل على شهادة الآيزو.
Do I need a genetic counselling session before this test?
Yes, a pre‑test genetic counselling session is mandatory to draw a family pedigree and explain the implications of a positive somatic mutation in the TET2 gene for your personal health and blood relatives.
نعم، جلسة الاستشارة الوراثية قبل الفحص إلزامية لرسم شجرة العائلة وشرح الآثار المترتبة على وجود طفرة جسدية في جين TET2 على صحتك وأفراد عائلتك من الدرجة الأولى.
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) · DHA Facility License 9834453
Compliance: UAE Federal Decree‑Law No. 41 of 2024 · UAE PDPL · CDS Law 2026 (Minors) · DHA genetic testing regulations.
Code Mapping: 2026 ICD‑10‑CM D46.9, D46.2, D46.0 (MDS sub‑types) · Genetic susceptibility Z15.09 · LOINC: 86204-6 (TET2 gene targeted mutation analysis).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians